{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:05:33Z","timestamp":1778724333828,"version":"3.51.4"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>To investigate adolescent vaccination in New York City, we assessed tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MCV4), and human papillomavirus (HPV) vaccine uptake, vaccine co-administration, and catch-up coverage over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>We analyzed data from the Citywide Immunization Registry, a population-based immunization information system, to measure vaccine uptake and co-administration, defined as a Tdap vaccination visit where MCV4 or HPV vaccine was co-administered, among 11-year-olds. Catch-up vaccinations were evaluated through 2013 for adolescents born 1996 to 2000, by birth cohort. HPV vaccination among boys included data from 2010 to 2013.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Adolescent vaccine administration was greatest during the back-to-school months of August to October and was highest for Tdap. Although MCV4 uptake improved over the study years, HPV vaccine uptake among girls stagnated; boys achieved similar uptake of HPV vaccine by 2012. By 2013, 65.4% had MCV4 co-administered with Tdap vaccine, whereas 28.4% of girls and 25.9% of boys had their first dose of HPV vaccine co-administered. By age 17, Tdap and MCV4 vaccination coverage increased to 97.5% and 92.8%, respectively, whereas \u22651-dose and 3-dose HPV vaccination coverage were, respectively, 77.5% and 53.1% for girls and 49.3% and 21.6% for boys. Age-specific vaccination coverage increased with each successive birth cohort (P &amp;lt; .001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>From 2007 to 2013, there were greater improvements in Tdap and MCV4 vaccination than HPV vaccination, for which co-administration with Tdap vaccine and coverage through adolescence remained lower. Parent and provider outreach efforts should promote timely HPV vaccination for all adolescents and vaccine co-administration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2014-1452","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T01:34:00Z","timestamp":1415669640000},"page":"e1576-e1583","source":"Crossref","is-referenced-by-count":15,"title":["Adolescent Vaccine Co-administration and Coverage in New York City: 2007\u20132013"],"prefix":"10.1542","volume":"134","author":[{"given":"Monica","family":"Sull","sequence":"first","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Eavey","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"},{"name":"Center for Health Statistics, Washington Department of Health,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikki","family":"Papadouka","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Mandell","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"},{"name":"Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"},{"name":"Atlantic Management Center, Inc., Columbus, Ohio; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane R.","family":"Zucker","sequence":"additional","affiliation":[{"name":"Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, New York;"},{"name":"Immunization Services Division\/National Center for Immunization and Respiratory Diseases\/Centers for Disease Control & Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2021120906260280700_B1","first-page":"1","article-title":"Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.","volume":"45","author":"Immunization of Adolescents Recommendations of the Advisory Committee on Immunization Practices","year":"1996","journal-title":"MMWR Recomm Rep"},{"key":"2021120906260280700_B2","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"2021120906260280700_B3","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"2021120906260280700_B4","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"34","key":"2021120906260280700_B5","first-page":"885","article-title":"National vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2006.","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906260280700_B6","unstructured":"Centers for Disease Control and Prevention (CDC). CDC Preteen and Teen Vaccine Communication Campaign. Updated May 20, 2011. Available at: www.cdc.gov\/vaccines\/who\/teens\/campaigns.html. Accessed December 25, 2013"},{"key":"2021120906260280700_B7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(99)00290-X","article-title":"The immunization system in the United States: the role of school immunization laws.","volume":"17","author":"Orenstein","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"2021120906260280700_B8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jadohealth.2006.12.013","article-title":"The impact of state policies on vaccine coverage by age 13 in an insured population.","volume":"40","author":"Olshen","year":"2007","journal-title":"J Adolesc Health"},{"issue":"6","key":"2021120906260280700_B9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jadohealth.2005.07.009","article-title":"The impact of a school entry law on adolescent immunization rates.","volume":"37","author":"Wilson","year":"2005","journal-title":"J Adolesc Health"},{"issue":"31","key":"2021120906260280700_B10","first-page":"660","article-title":"Effectiveness of a middle school vaccination law\u2014California, 1999\u20132001.","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906260280700_B11","unstructured":"New York State Department of Health. Sixth grade entry law for Tdap immunizations. School administrator letter. March 2007. Available at: www.health.ny.gov\/prevention\/immunization\/schools\/sixth_grade_entry_law_for_tdap.htm. Accessed November 7, 2013"},{"key":"2021120906260280700_B12","unstructured":"Public Health Law 2164.2.b. New York State Legislature. Available at: http:\/\/public.leginfo.state.ny.us\/LAWSSEAF.cgi?QUERYTYPE=LAWS+&QUERYDATA=$$PBH2164$$@TXPBH02164+&LIST=LAW+&BROWSER=EXPLORER+&TOKEN=59252407+&TARGET=VIEW. Accessed May 14, 2010"},{"key":"2021120906260280700_B13"},{"issue":"20","key":"2021120906260280700_B14","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"2021120906260280700_B15","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2021120906260280700_B16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.acap.2014.03.005","article-title":"Uptake of human papillomavirus vaccine among adolescent males and females: immunization information system sentinel sites, 2009\u20132012.","volume":"14","author":"Cullen","year":"2014","journal-title":"Acad Pediatr"},{"issue":"8","key":"2021120906260280700_B17","first-page":"174","article-title":"Two-dose varicella vaccination coverage among children aged 7 years\u2014six sentinel sites, United States, 2006\u20132012.","volume":"63","author":"Lopez","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906260280700_B18"},{"issue":"5","key":"2021120906260280700_B19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1054-139X(03)00343-4","article-title":"Effect of middle school entry requirements on hepatitis B vaccination coverage.","volume":"34","author":"Jacobs","year":"2004","journal-title":"J Adolesc Health"},{"issue":"9","key":"2021120906260280700_B20","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2105\/AJPH.2009.179341","article-title":"Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade.","volume":"100","author":"Kharbanda","year":"2010","journal-title":"Am J Public Health"},{"issue":"29","key":"2021120906260280700_B21","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006\u20132014\u2014United States.","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906260280700_B22","unstructured":"Centers for Disease Control and Prevention (CDC). Q&A about IIS Sentinel Sites. Updated February 25, 2014. Available at: www.cdc.gov\/vaccines\/programs\/iis\/activities\/sentinel-sites.html. Accessed May 12, 2014"},{"issue":"4","key":"2021120906260280700_B23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1542\/peds.2007-2857","article-title":"Adolescent immunizations: missed opportunities for prevention.","volume":"122","author":"Lee","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"2021120906260280700_B24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jadohealth.2013.05.009","article-title":"Missed opportunities for adolescent vaccination, 2006\u20132011.","volume":"53","author":"Wong","year":"2013","journal-title":"J Adolesc Health"},{"issue":"29","key":"2021120906260280700_B25","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2013.","volume":"63","author":"Elam-Evans","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021120906260280700_B26"},{"issue":"2","key":"2021120906260280700_B27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JRS-2011-0529","article-title":"Postlicensure safety evaluation of human papilloma virus vaccines.","volume":"23","author":"Labadie","year":"2011","journal-title":"Int J Risk Saf Med"},{"issue":"19","key":"2021120906260280700_B28","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"2021120906260280700_B29","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120906260280700_B30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1542\/peds.2012-2384","article-title":"Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008\u20132010.","volume":"131","author":"Darden","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"2021120906260280700_B31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","article-title":"Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.","volume":"168","author":"Holman","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2021120906260280700_B32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pedn.2011.09.005","article-title":"Testing a model for parental acceptance of human papillomavirus vaccine in 9- to 18-year-old girls: a theory-guided study.","volume":"27","author":"Reynolds","year":"2012","journal-title":"J Pediatr Nurs"},{"issue":"6","key":"2021120906260280700_B33","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1542\/peds.2011-1048","article-title":"Adolescent vaccination-coverage levels in the United States: 2006\u20132009.","volume":"128","author":"Stokley","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"2021120906260280700_B34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0009922812468208","article-title":"Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey\u2013Teen, 2010.","volume":"52","author":"Dorell","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"2021120906260280700_B35","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1016\/j.whi.2012.09.003","article-title":"Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women.","volume":"22","author":"Joseph","year":"2012","journal-title":"Womens Health Issues"},{"issue":"3","key":"2021120906260280700_B36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1542\/peds.2009-3500","article-title":"Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure.","volume":"126","author":"Daley","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"2021120906260280700_B37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1542\/peds.2012-3495","article-title":"Sexual initiation, contraceptive use, and pregnancy among young adolescents.","volume":"131","author":"Finer","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"2021120906260280700_B38","first-page":"1","article-title":"Youth risk behavior surveillance: United States, 2009.","volume":"59","author":"Eaton","year":"2010","journal-title":"MMWR Surveill Summ"},{"key":"2021120906260280700_B39","unstructured":"Centers for Disease Control and Prevention. Incidence, prevalence, and cost of sexually transmitted infections in the United States. 2013. Available at: www.cdc.gov\/std\/stats\/STI-Estimates-Fact-Sheet-Feb-2013.pdf. Accessed April 17, 2014"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/6\/e1576\/1094260\/peds_2014-1452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/6\/e1576\/1094260\/peds_2014-1452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:48:07Z","timestamp":1639097287000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/6\/e1576\/33165\/Adolescent-Vaccine-Co-administration-and-Coverage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-1452","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}